Atlas Trials

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Clinical trial NCT06344247 · UNKNOWN

Trial details

NCT number
NCT06344247
Sponsor
RenJi Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
ObesityChronic Kidney Diseases
Start date
2023-09-01
Primary completion
2025-09-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.